Home
Products
Learn
About
Pricing
Log In
GERN
Asset Logo

Geron Corporation

🇺🇸 NYSE/NASDAQ

📈 HIGH PRICE GROWTH

Compare
Add to watchlist
👑 Overview

📈 Performance

💵 Cost

🍃 Esg

🤓 Advanced

👨‍👩‍👧‍👦 Community

📈

+ 8.00%
Annual Growth

5 years average annual capital growth

🌏

1
Pearlers Invested

Since January 2020

👑 Overview

Key information
🔎 Fund Overview

Geron Corporation is a late-stage clinical biopharmaceutical company developing investigational first-in-class telomerase inhibitor, imetelstat, to treat hematologic malignancies. The Company is engaged in the development of therapeutic products for oncology. Its lead indication for imetelstat is in Low or Intermediate-1 risk myelodysplastic syndromes. It is developing imetelstat for the treatment of several myeloid hematologic malignancies, including a Phase 3 clinical trial, named IMpactMF, in relapsed/refractory myelofibrosis (MF) with overall survival as the primary endpoint, that is enrolling patients. It is also conducting a Phase 1 combination therapy clinical trial, named IMproveMF, in first-line Intermediate-1, Intermediate-2 or High-Risk myelofibrosis, or frontline MF, that is enrolling patients and imetelstat is being studied in an investigator-led Phase 2 clinical trial, named IMpress, in Intermediate-2 or High-Risk myelodysplastic syndromes and acute myeloid leukemia.

📈 Performance

Price History*

-60.54%

1M

1Y

10Y

Graph

Table

* US price history does not take into account stock splits

Unsure how much or often to invest?
🗓️ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out →
💵 Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out →
⏱️ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out →

💵 Costs

💵

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

💼

N/A
Management Fee

Included in unit price, not charged by Pearler

💸

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator

🤓 Advanced information

Technical Info

💰 Price*

$1.47

*Price may be up to 24 hours old

👩‍👩‍👦 Community Insights

How our community is investing

🌏 Pearlers invested in GERN

0

📊 Total Capital Earnings

N/A

🔃 Average investment frequency

24 weeks

💵 Average investment amount

$208

Last time a customer invested in GERN

118 days
GERN investor breakdown
💵 Income of investors

More than 200k

150k - 200k

100k - 150k

50k - 100k

Less than 50k

👶 Age of investors

18 - 25

26 - 34

35 - 90

🙋 Legal gender of investors

Female

Male

Pearlers who invest in GERN also invest in...

Halozyme Therapeutics, Inc.

HALO

🙌 Performance (5Yr p.a)

56.35%

📊 Share price

$61.92 USD
Find Out More

🙌 Performance (5Yr p.a)

24.04%

📊 Share price

$93.80 USD

📈 HIGH PRICE GROWTH

🙌 Performance (5Yr p.a)

728.94%

📊 Share price

$178.41 USD

🙌 Performance (5Yr p.a)

16.06%

📊 Share price

$74.34 USD

📈 HIGH PRICE GROWTH

🙌 Performance (5Yr p.a)

68.16%

📊 Share price

$89.44 USD

Want more shares? Try these...

🙌 Performance (5Yr p.a)

13.27%

📊 Share price

$10.04 USD

📈 HIGH PRICE GROWTH

🙌 Performance (5Yr p.a)

5.14%

📊 Share price

$6.94 USD
Compare
Add to watchlist